ARTICLE | Company News
Cell Therapeutics, Teva deal
December 9, 2013 8:00 AM UTC
Cell Therapeutics received a $5 million milestone payment from Teva under a 2005 deal in which Cephalon Inc. acquired Cell Therapeutics' Trisenox arsenic trioxide for acute promyelocytic leukemia. ...